Patient Square Capital Closes $3.9 Billion Inaugural Fund
Summary
LPs include a diverse and global set of institutional investors, including leading sovereign wealth funds, pension funds, endowments, foundations, family offices, health systems, consultants, private wealth platforms, and insurance companies. The firm invests broadly across the health care industry, including development-stage therapeutics; commercial-stage pharmaceuticals; medical devices, diagnostics, and life science tools; health care providers; and technology-enabled and other services. Portfolio companies include Access Telecare, Apollo Therapeutics, Eargo, Enavate Sciences, Hanger Inc., Kriya Therapeutics, Radius Health, Resolve Biosciences, and Summit BHC. The firm utilizes industry expertise, a broad network of relationships and a partnership approach to make investments in companies grow and thrive. Patient Square’s total assets under management (“AUM”) is approximately $5.9 billion, including significant co-investment commitments from leading institutional investors.